U-EVAX

Q:EVAX - EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS - https://www.evaxion-biotech.com/

20:58:30 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
EVAX - Q	0.1	0.7454	·	0.9627	0.1	0.833	+0.01	1.2	111.4	89	108	0.899 0.899 0.8113	3.10 0.4701	19:44:38	Sep 20	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 108

More trades...

Time ET	Ex	Price	Change	Volume
19:44:38	Q	0.8746	0.0246	5
19:05:00	Q	0.8397	-0.0103	4
19:05:00	Q	0.8048	-0.0452	1
16:53:37	Q	0.8393	-0.0107	1
15:59:16	Q	0.833	-0.017	300
15:59:16	Q	0.833	-0.017	100
15:59:16	Q	0.833	-0.017	9
15:58:35	Q	0.86	0.01	132
15:49:14	Q	0.8401	-0.0099	40
15:46:28	Q	0.8449	-0.0051	13

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-09-20 08:26	U:EVAX	News Release200	Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
2023-09-18 08:23	U:EVAX	News Release200	Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company
2023-09-11 08:17	U:EVAX	News Release200	Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development

Date ET

Symbol

Type

Headline

2023-09-20 08:26

U:EVAX

News Release

Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea

2023-09-18 08:23

U:EVAX

News Release

Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company

2023-09-11 08:17

U:EVAX

News Release

Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development